Iranian Red Crescent Medical Journal

Published by: Kowsar

Evaluation of serum cyfra21 in patients with pleural effusion

Q Azimi 1 , B Rezadoost 2 , M Jalali Nadoushan 2 , * and A Davati 3
Authors Information
1 Dept. of Internal Medicine, Shahed University, Tehran, Iran
2 Dept. of Pathology, Faculty of Medicine, Shahed University, Tehran, Iran
3 Dept of Social Medicine, Shahed University, Tehran, Iran
Article information
  • Iranian Red Crescent Medical Journal: October 30, 2012, 14 (10); 613-617
  • Published Online: October 30, 2012
  • Article Type: Research Article
  • Received: June 25, 2011
  • Revised: February 1, 2012
  • Accepted: February 12, 2012

To Cite: Azimi Q, Rezadoost B, Jalali Nadoushan M, Davati A. Evaluation of serum cyfra21 in patients with pleural effusion, Iran Red Crescent Med J. 2012 ; 14(10):613-617.

Abstract
Copyright © 2012, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Introduction
Materials and Methods
Results
Discussion
Acknowledgements
References
  • 1. Fauci AS, Braunwald E, Kasrer DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. 2008;
  • 2. Light RW, Lee YC. Textbook of Pleural Diseases. 2008;
  • 3. Paganuzzi M, Onetto M, Marroni P, Filiberti R, Tassara E, Parodi S, Felletti R. Diagnostic value of CYFRA 21-tumor marker and CEA in pleural effusion due to mesothelioma. Chest. 2001; 119(4): 1138-42[DOI][PubMed]
  • 4. Lee JH, Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Chest. 2005; 128(4): 2298-303[DOI][PubMed]
  • 5. S Romero, C Fernandez, JM Arriero, A Espasa, A Candela, C Martin, Sánchez-Payá J. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions. Eur Respir J. 1996; 9: 17-23[DOI][PubMed]
  • 6. Dejsomritrutai W, Senawong S, Promkiamon B. Diagnostic utility of CYFRA 21-1 in malignant pleural effusion. Respirology. 2001; 6(3): 213-6[DOI][PubMed]
  • 7. Porcel JM, Vives M, Esquerda A, Salud A, Pérez B, Rodríguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest. 2004; 126(6): 1721-2[DOI][PubMed]
  • 8. Wagner IC, Guimarães MJ, da Silva LK, de Melo FM, Muniz MT. Evaluation of serum and pleural levels of thetumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion. J Bras Pneumol. 2007; 33(2): 185-91[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments